Dipeptidyl peptidase-4 inhibitor compared with sulfonylurea in combination with metformin: cardiovascular and renal outcomes in a propensity-matched cohort study

BACKGROUND: To determine the impact of dipeptidyl peptidase-4 inhibitor (DPP4i) on the risk of major cardiocerebrovascular and renal outcomes compared with sulfonylurea (SU) combined with metformin in patients with type 2 diabetes from a population-based cohort. METHODS: From a nationwide cohort in...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cardiovasc Diabetol
Hlavní autoři: Kim, Kyoung Jin, Choi, Jimi, Lee, Juneyoung, Bae, Jae Hyun, An, Jee Hyun, Kim, Hee Young, Yoo, Hye Jin, Seo, Ji A., Kim, Nan Hee, Choi, Kyung Mook, Baik, Sei Hyun, Kim, Sin Gon, Kim, Nam Hoon
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
Original Investigation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6410523/
https://ncbi.nlm.nih.gov/pubmed/30857540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-019-0835-z
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky